Evaluating study drug ARGX-117 in Adults With Multifocal

Build status - In Progress

Recruiting

18 years - 99 years

All

3 participants needed

1 Location

Brief description of study

The main goal of this study is to look at the safety and effect of a drug called ARGX-117 in people with multifocal motor neuropathy (MMN). Other goals of the study are to collect information about: • How well different doses of ARGX-117 work • How your body removes ARGX-117 over time (known as “pharmacokinetics”) • What ARGX-117 does to your body (known as “pharmacodynamics”) • How your immune system reacts to ARGX-117 • The impact of ARGX-117 on certain biomarkers and proteins

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Multifocal Motor Neuropathy
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 850467

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.